Chemicals and Active Pharmaceutical
Ingredients (APIs) and intermediate
product manufacturers
and a strategic industrial sector due to the
relevance of its production, the ingredients
for the pharmaceutical industry
and current pharmaceutical products
PRODUCT BROWSER
Use our browser to find our member products
**This browser does not offer prices or product sales.
To request additional information about companies or products, please contact the manufacturers directly.
The sector
About Fine Chemicals, Active Pharmaceutical Ingredients (APIs) and intermediate products.
The Industry
The Spanish APIs industry is leader in Europe and a strategic industrial sector due to the relevance of its production, the ingredients for the pharmaceutical industry.
ABOUT US
AFAQUIM is the national voice of Fine Chemicals manufacturers.
AFAQUIM is the national voice of Fine Chemicals and Active Pharmaceutical Ingredients (APIs) and intermediate product manufacturers.
Created July 1st, 1980, AFAQUIM is formed by 32 companies, some integrated into international groups although most are independent manufacturers.
OUR MEMBERS
Created July 1st, 1980, AFAQUIM is formed by 32 companies, some integrated
into international groups although most are independent manufacturers.
Facts & figures
The Active Ingredient and pharmaceutical intermediates sector in Spain represents a turnover of over 2,000 million Euros and export about 80% of its production.
Join us!
AFAQUIM represents, defends and promotes the economic, social, professional, scientific and technical interests of its members, following Sustainable Development mandates.
Collaborate!
Collaborating with AFAQUIM means
access to a leading sector in Europe. Discover the different possibilities
of collaboration with AFAQUIM and its advantages.
NEWS
Joint statement by EFCG and BPTF on addressing the challenges of the pharmaceutical supply chain
Strategic autonomy of the pharmaceutical supply chain is essential to the sustainability of patient care in the U.S. and the EU The existence of generic drugs has helped to counterbalance the cost of more innovative medicines for decades. As the price of generics tends to consistently decline due to administrative cost-containment policies on both sides […]
Open borders that prioritize essential goods: key to the supply of medicines in Europe
El sistema de fronteras abiertas de Schengen es clave para la movilidad y el mercado interno de la Unión Europea (UE), incluyendo los medicamentos esenciales. Su implementación coherente entre los Estados miembros es fundamental para garantizar el flujo continuo de medicamentos entre países, desde las fábricas a miles de hospitales y farmacias, garantizando así el abastecimiento. La experiencia de la […]
Feique and Trade Unions reach a preliminary agreement in the negotiation of the XX General Agreement of the Chemical Industry with wage increases of 1 and 2% and improvements in the areas of teleworking, equality and sustainability
El XX CGIQ afectará a más de 300.000 trabajadores y tendrá una vigencia de tres años. El texto contempla incrementos salariales del 1% en 2021 y del 2% para 2022 y 2023. Recoge mejoras estratégicas en los ámbitos de trabajo a distancia, igualdad y desarrollo sostenible del sector, además de la inclusión de medidas específicas […]
Farmaindustria and Afaquim meet to advance the tractor project on essential medicines
La iniciativa se enmarca en el Programa de Impulso de proyectos tractores de Competitividad y Sostenibilidad Industrial y aspira a ser uno de los elegidos por el Gobierno para la reactivación de España.El proyecto, que implica una inversión mínima de 500 millones, pretende aglutinar a muchas de las empresas estratégicas para nuestro país en fabricación […]
Follow us